Article Details
Retrieved on: 2022-05-03 16:36:54
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The FDA approved daridorexant in January 2022 to treat insomnia after it showed improvements in changes in latency to persistent sleep and wake ...
Article found on: www.pharmacytimes.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here